13.8 C
Sunday, November 29, 2020

Study shows hydroxychloroquine may be effective for outpatients with COVID-19

The controversy over hydroxychloroquine will not go away.

The anti-malarial drug gained attention in March when President Trump said he was using it to prevent COVID-19. In May, the medical journal the Lancet published a study saying that the drug was potentially toxic, a study that was retracted in June because its data proved to be fraudulent. The Food and Drug Administration issued an emergency use authorization for the drug in late March and then revoked it in June when new evidence suggested it was ineffective. Then, in late July, a group calling itself America’s Frontline Doctors generated controversy by releasing a video touting hydroxychloroquine as a treatment for COVID-19. The video was pulled by Facebook, YouTube, and Twitter.

Now a new, peer-reviewed study in the International Journal of Antimicrobial Agents may add fuel to a fire that seemed to be burning out. The study finds that outpatients with the coronavirus who were treated with hydroxychloroquine combined with zinc and the antibiotic azithromycin were less likely to be hospitalized. Fewer than 3% of outpatients who took the drug regimen ended up in the hospital versus 15% who did not take it.

A number of studies have found that hydroxychloroquine has no effect on inpatients. But critics have said that patients who are already in the hospital may be too sick for the drug to have any effect. Outpatients, they claim, often present with milder symptoms, and thus, hydroxychloroquine may prove effective.

But the new study has limitations. First is its relatively small sample size of 518 patients. Second, it is a retrospective study, not a randomized controlled trial, often considered the gold standard in medical research. Additionally, one of the authors, Dr. Vladimir Zelenko, has aggressively promoted hydroxychloroquine as a COVID-19 treatment, at one point incorrectly saying that he was conducting an FDA-approved study of the drug.

In June, the New England Journal of Medicine published the results of a randomized controlled trial of hydroxychloroquine on outpatients that found no effect. However, it did not include zinc or azithromycin in its study. Randomized controlled trials examining all three drugs are due out later this year.

Read More at Washingtonexaminer

Latest news

Trump floats appointing a ‘special prosecutor’ in addition to John Durham to investigate Trump-Russia investigators

President Trump said he would “consider” appointing a “special prosecutor” to investigate the...

Iran threatens Biden with nuclear buildup over Israel assassination

On Sunday, Iran responded aggressively to Israel's assassination on Friday of its top nuclear...

Officials raid home of Diego Maradona’s doctor, probe death as manslaughter case

Argentine investigators raided the home of Diego Maradona’s doctor on Sunday as they probe a possible case of involuntary manslaughter in the soccer legend’s...

Chinese Government Stepping Up Propaganda To Change COVID Origin Story

Authored by Rick Moran via PJMedia.com,The Chinese Communist government is stepping up its PR campaign to try and convince the world that the coronavirus...

Related news

CDC warning does not deter some Black Friday shoppers

The Centers for Disease Control and Prevention urged people to avoid shopping in crowded...

Biden urges people to fulfill their ‘patriotic duty’ and ‘forgo’ Thanksgiving traditions to slow coronavirus

President-elect Joe Biden said it is the public's “patriotic duty” to “forgo” Thanksgiving traditions...

Vermont governor announces school leaders will ask students about being in ‘multi-family gatherings’ over Thanksgiving

Vermont Gov. Phil Scott said the state's Agency of Education is directing schools to...

Obamacare Boosts Colon Cancer Care, Diagnosis

Colon cancer treatment for...

Mediterranean Diet Cuts Women’s Odds for Diabetes

Overweight women who eat...